Amedisys Inc (AMED) Stock

DelistedNasdaq: AMEDAmedisys, Inc.

100.99
Final close · Aug 14, 2025

AMED is no longer traded. Amedisys was acquired by UnitedHealth Group (UNH) on August 14, 2025.

Each AMED share was exchanged for $101.00 in cash. Prices on this page are historical; the last trade was August 14, 2025 at $100.99.

See UnitedHealth Group (UNH) stock →

Amedisys stock price history

Split-adjusted closes, 1994–2025

AMED final trading statistics

Final close
$100.99
Final trading day
Aug 14, 2025
Market cap at delisting
$3.32B
Shares outstanding
32.89M
Final 52-week range
$82.15 – $101.02
Avg. volume (final 3 mo.)
505,619
All-time high (split-adj.)
$314.16 · Jan 2021
All-time low (split-adj.)
$0.77 · May 1999
Return since IPO
+1823.6%
Beta
0.90
Book value / share
$37.48
Price / book
2.69
Final 52 wk
82.15101.02

Amedisys earnings per share

Earnings per share

Amedisys revenue & net income

RevenueNet income

Amedisys annual financials

Fiscal yearRevenueNet incomeEPS
FY2024$2.35B$43.2M$4.31
FY2023$2.24B-$9.7M$4.29
FY2022$2.22B$118.6M$5.01
FY2021$2.21B$209.1M$5.94
FY2020$2.07B$183.6M$6.12

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Amedisys Inc

Amedisys, Inc. provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment provides a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was formerly known as Analytical Nursing Management Corp. and changed its name to Amedisys, Inc. in August 1995. The company was founded in 1982 and is headquartered in Baton Rouge, Louisiana with an additional office in Nashville, Tennessee. As of August 14, 2025, Amedisys, Inc. operates as a subsidiary of Optum, Inc.

Amedisys stock FAQ

What happened to Amedisys stock?

Amedisys was acquired by UnitedHealth Group (UNH) on August 14, 2025. Shareholders received $101.00 in cash for each share. AMED stock stopped trading on the Nasdaq, with a final close of $100.99 on August 14, 2025.

What did Amedisys shareholders receive?

Each AMED share was converted into $101.00 in cash. The deal was valued at about $3.3 billion.

Is AMED stock still trading?

No. AMED was delisted from the Nasdaq on August 14, 2025 and no longer trades on a U.S. exchange.

What was the last price of AMED stock?

AMED closed at $100.99 on its final trading day, August 14, 2025, for a market value of about $3.32B.

What were Amedisys's revenue and earnings in its last full fiscal year?

Amedisys reported revenue of $2.35B and net income of $43.2M in fiscal 2024, its last full year as a public company.

When did Amedisys go public?

Amedisys Inc stock began trading on August 17, 1994.

Medical Care Facilities stocks to research

All Healthcare stocks →